183 related articles for article (PubMed ID: 17914715)
21. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials.
Lai TL; Shih MC; Zhu G
Stat Med; 2006 Apr; 25(7):1149-67. PubMed ID: 16189814
[TBL] [Abstract][Full Text] [Related]
22. A framework for two-stage adaptive procedures to simultaneously test non-inferiority and superiority.
Koyama T; Sampson AR; Gleser LJ
Stat Med; 2005 Aug; 24(16):2439-56. PubMed ID: 15977285
[TBL] [Abstract][Full Text] [Related]
23. Implementing type I & type II error spending for two-sided group sequential designs.
Rudser KD; Emerson SS
Contemp Clin Trials; 2008 May; 29(3):351-8. PubMed ID: 17933592
[TBL] [Abstract][Full Text] [Related]
24. Alternatives for discounting in the analysis of noninferiority trials.
Snapinn SM
J Biopharm Stat; 2004 May; 14(2):263-73. PubMed ID: 15206525
[TBL] [Abstract][Full Text] [Related]
25. The adjustment of the type I error rate in noninferiority trials with λ-margin approach: each of two different new drugs is approved with two independent trials with the same active control.
Kang SH; Ryu Y
J Biopharm Stat; 2011 May; 21(3):498-510. PubMed ID: 21442522
[TBL] [Abstract][Full Text] [Related]
26. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
Carroll KJ
Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
[TBL] [Abstract][Full Text] [Related]
27. [Methodological and statistical aspects of equivalence and non inferiority trials].
Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
[TBL] [Abstract][Full Text] [Related]
28. A group-sequential design for clinical trials with treatment selection.
Stallard N; Friede T
Stat Med; 2008 Dec; 27(29):6209-27. PubMed ID: 18792085
[TBL] [Abstract][Full Text] [Related]
29. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials.
Schwartz TA; Denne JS
Stat Med; 2006 Oct; 25(19):3396-406. PubMed ID: 16900573
[TBL] [Abstract][Full Text] [Related]
30. Indirect comparisons in the comparative efficacy and non-inferiority settings.
Snapinn S; Jiang Q
Pharm Stat; 2011; 10(5):420-6. PubMed ID: 21956948
[TBL] [Abstract][Full Text] [Related]
31. Power and sample size when multiple endpoints are considered.
Senn S; Bretz F
Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
[TBL] [Abstract][Full Text] [Related]
32. ['Non-inferiority' trials. Tips for the critical reader. Research methodology 3].
Soonawala D; Dekkers OM
Ned Tijdschr Geneeskd; 2012; 156(19):A4665. PubMed ID: 22571548
[TBL] [Abstract][Full Text] [Related]
33. The ABC of non-inferiority margin setting from indirect comparisons.
Julious SA
Pharm Stat; 2011; 10(5):448-53. PubMed ID: 21928354
[TBL] [Abstract][Full Text] [Related]
34. Three-sided hypothesis testing: simultaneous testing of superiority, equivalence and inferiority.
Goeman JJ; Solari A; Stijnen T
Stat Med; 2010 Sep; 29(20):2117-25. PubMed ID: 20658478
[TBL] [Abstract][Full Text] [Related]
35. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
Hirotsu C
Pharm Stat; 2007; 6(3):193-203. PubMed ID: 17879327
[TBL] [Abstract][Full Text] [Related]
36. Likelihood ratio and a Bayesian approach were superior to standard noninferiority analysis when the noninferiority margin varied with the control event rate.
Kim MY; Xue X
J Clin Epidemiol; 2004 Dec; 57(12):1253-61. PubMed ID: 15617951
[TBL] [Abstract][Full Text] [Related]
37. Semiparametric bayesian testing procedure for noninferiority trials with binary endpoints.
Osman M; Ghosh SK
J Biopharm Stat; 2011 Sep; 21(5):920-37. PubMed ID: 21830923
[TBL] [Abstract][Full Text] [Related]
38. On non-inferiority analysis based on delta-method confidence intervals.
Rothmann MD; Tsou HH
J Biopharm Stat; 2003 Aug; 13(3):565-83. PubMed ID: 12921402
[TBL] [Abstract][Full Text] [Related]
39. Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints.
Tang NS; Yu B; Tang ML
BMC Med Res Methodol; 2014 Dec; 14():134. PubMed ID: 25524326
[TBL] [Abstract][Full Text] [Related]
40. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
